Objective: The binding characteristics of the polyene antifungal amphotericin B (AmB) are still arguably unclear 50 years after the first human treatment. Our purpose was to investigate the dynamic of polyene cell associated binding using an AmB directed antibody.
INTRODUCTION
Traditionally, the antifungal actions of amphotericin B [AmB] have been attributed to ergosterol binding to yeast and moulds. Polyenes like AmB have long been proposed to interact with mammalian cell membrane sterol (3-13-hydroxy sterols), similar to ergosterol [1] . However, polyenes appear to bind with greater affinity to ergosterol containing membranes [2] . Both interactions have been reported to result in aqueous pore production. In unilamellar vesicles or cellular bilayers an annulus of eight AmB molecules can link hydrophobically to the membrane sterols [3] . The pore is configured with the polyene hydroxyl residues facing inward, leading to increased cell permeability, leakage of vital cytoplasmic components, and cell death [4] [5] [6] . Our purpose was to investigate the dynamic of polyene cell associated binding using an AmB directed antibody.
MATERIALS AND METHODS
Immunohistology and transmission electron microscope exploration of polyene cell associated binding were used in 
REAGENTS Amphotericin B Products and Controls
The pharmacologic agents utilized included commercial grade AmB (Fungizone, Squibb; Princeton, NJ), liposomal AmB (Nexstar Pharmaceuticals, Boulder, CO; L-AmB), lipid complex AmB (Elan Pharmamceuticals, Bridgewater, NJ; ABLC), AmB high purity (University of Mississippi Mycotic Research Center, AmBHP) [7] ; Escherichia coli endotoxin (Serotype 026:b6 lipopolysaccharide, Sigma; St. Louis, MO) (LPS). Desoxycholate and sodium phosphate buffer were obtained from Sigma Chemical (St. Louis, MO) and empty liposomes from Nexstar Pharmaceuticals.
Antibody
A polyclonal rabbit antibody was isolated from New Zealand white rabbits after standard immunization with generic, desoxycholate solubilized AmB complexed with an immune adjuvant, Keyhole Limpet Hemocyanin. An antiAmB antibody was purified by filtering serum through an Aminolink Affinity-Pak Column (ImmunoPure Ag/Ab; Pierce Chemical Co., Rochford, IL) which was coupled with polyene. Column effluent was passed over a Protein G Column (Pierce Chemical Co., Rochford, IL) in order to separate immunoglobulin G (IgG) from immunoglobulin M (IgM). Evaluation of IgG purification process was validated utilizing a 7.5% SDS polyacrylamide gel. The final samples of anti-AmB IgG were frozen at -70 0 C until further use [8] .
Gold Bead Labeling
The procedure for colloidal gold conjugation antibodies has been described previously [9] . In brief, our method was modified in that a primary polyclonal rabbit antibody was used. Colloidal gold 8 -12nm particle diameter (Sigma; St. Louis, MO) was adjusted to pH = 9 with potassium acetate then conjugated with the antibody. An anti-AmB sample was diluted to a final protein concentration of 12 uM. This concentration was selected so there was a molar excess of antibody to "antigen". The ratio calculated was 4.4x based on each experimental well containing 27 uM antibody. 6 cells/mL in supplemented media (RPMI-1640, 10% autologous serum, 100 ug/mL streptomycin and 100 u/mL penicillin). One milliliter of MNCs was seeded in Limbro 24 well plates (Flow Laboratories; McLean, VA) and incubated for one hour at 37 o C in a 5% CO 2 prior to any study procedure. Initially, MNCs viability was assessed with tritiated [
In Vitro Cell isolation and Preparation
3 H] thymidine (1 Ci/10 6 cells; 62.5 pmol/ Ci) (Perkin Elmer, Boston, MA) incorporation was used to assess cytotoxicities of agents at varying concentrations and times of in vitro exposure ( Fig. 1) and a nonspecific esterase stain was used to assess cell type. Aliquots of AmB solutions were added to cell culture wells, and the final concentrations of AmB preparations were obtained by addition of an equal volume of cell suspension. After establishing viability, the ability of MNCs to exclude trypan blue, as followed by light microscopy using routine procedures, was used to provide an assessment of cytotoxicity.
Average serum concentrations achieved in humans during FDA recommended AmB formulation dosing is 1.2uM for AmB, 83uM for Ambisome and 1.7uM for Abelcet. These concentrations were used in all in vitro exposure studies. High purity AmB has not undergone licensing trials at this time and no human serum concentrations are known. Therefore, serum concentrations achieved for generic amphotericin were used in AmBHP studies [7] . Reagents were diluted for in vitro studies with sterile water so that 0.01 mL of stock solutions added to culture wells resulted in the final concentrations noted. Samples from diluent (sterile water), media, reagents and flushed wells from culture plates were assayed for endotoxin utilizing the limulus amebocyte lysate. The limulus amebocyte lysate (Associates of Cape Cod Inc.; Woodshole, MA) testing employed an Escherichia coli endotoxin standard with a lower limit of detection of 3.0 pg/mL. No reagents screened were positive. Media harvested from cellfree wells of culture plates were likewise negative.
Immunohistochemistry for AmB
In in vivo studies were performed after IACUC animal committee approval. One of the AmB formulations (0.5mg/kg of a non-lipid AmB formulation or 5mg/kg of a lipid formulation) were administered intraperitoneally to fasting uninfected Balb/c mice over 2 minutes. These studies used AmB lipid complex as the only lipid formulation. At 24 hours the animals were sacrificed, vital organs (liver, spleen, liver & lung) were isolated and transferred into 2 mL cold sterile phosphate-buffered saline. Samples were frozen at -80 o C until analysis. Immunohistochemical staining was performed on routinely processed 4μm sections of paraffinembedded mouse tissue from animals treated with AmB formulations. Endogenous peroxidase was blocked in paraffin sections by immersing sections in 3% H 2 0 2 /PBS for 30 minutes. Antigen retrieval was performed on paraffin sections by steam heating sections for 30 minutes in Ag Retrieval Citra-Plus buffer (Biogenex Corp., San Ramon, CA). Endogenous biotin was blocked using Biotin Blocking System (DAKO Corp, Carpinteria, CA). Anti-AmB antibody at a concentration of ~3.5 M was applied on sections by incubating the section at 4 o C overnight followed by biotinylated goat anti-rabbit IgG at 1:1000 and peroxidase conjugated streptavidin-biotin complex (Vector Lab. Inc, Burlingame, CA), according to the kit instruction. Briefly, after wash in PBS, sections were incubated with biotinylated secondary antibody for 30 minutes at room temperature. Following wash in PBS, the conjugate was added on sections, incubating at room temperature for 30 minutes, then washed sections in PBS again. Color was developed with 3,3'-diaminobenzidine (Vector Lab Inc), and sections were counterstained with hematoxylin Gill2 (Sigma, St. Louis, MO) and mounted in Cytoseal 60 (Steohens Scientific, Kalamazoo, MI). 5 cells/mL and exposed to varying polyene concentrations for 24 hours. Percent viability was determined from untreated control measured values. At exposures less than 24 hours, viability was improved for polyene concentrations greater than 1uM.
The negative controls consisted of sections of the liver, kidney, spleen and lung incubated with non-immune serum provided by Elite ABC kit (Verctor Lab.) instead of primary antibody. In addition, control, untreated mouse tissue were utilized. All staining performance was assessed in a double bind manner until interpretation complete.
Transmission Electron Micrograph Study Procedure
Human monocytes cultured at 5 x 10 6 cells/mL were exposed to AmB for 5 minutes, 10 minutes, 20 minutes, 30 minutes, 1 hour, and 2 hours at either 4 o C or 37 o C in Coster 24 well culture plates. After exposure, cells were fixed. Visual identification of AmB was performed through complexing AmB in the cellular environment with an antibody bound to gold beads.
In pilot electron micrograph experiments, anti-AmB antibody bound to gold (AmBAg) was added to cultures 1 minute prior to fixing. These studies lead to micrograph studies that were un-interpretable. Washing and removing contaminating gold beads was difficult. In all further experiments, AmBAg was added after the cells were fixed, embedded and sliced for viewing. One milliliter of fixative (2.5% glutaraldehyde solution mixed to a final concentration of 0.1M Sorensen's phosphate buffer) at pH 7.4 was added to each 1.0mL cell culture. After fixing, cells were embedded in 1% osmium, sliced and reacted with uranly acetate, dehydrated with ethanol, critical point dried then viewed.
RESULTS
Our in vivo immunohistologic studies investigated polyene distribution in tissue from treated animals. A sandwich assay, using a primary antibody against AmB and a secondary anti-rabbit antibody labeled with streptavidinbiotin complex traced the polyene macroscopically. Diffuse binding was observed in these trials (Fig. 2) . However, cellular features were difficult to discriminate and assessment of cellular dynamics was un-illustrative. More sensitive gold bead immuno-labeling performed in polyene exposed human mononuclear cell cultures revealed thought provoking results (Figs. 3 & 4) . In general, isolated human MNCs studied in vitro and examined by electron micrograph supported a new hypothesis of polyene action at routinely achievable serum concentrations.
The average cell yield from 90cc of human blood was 1.0-2.0 x 10 8 cells with greater than 95% viability (established by Trypan Blue exclusion & tritiated thymidine). Viability was maintained at all 6 time points tested with exposure to AmB 1uM (Fig. 1) . A nonspecific esterase test revealed an average of 66.3% (+ 16.2) lymphocytes and 31.0% (+ 11.7) monocytes. By trypan blue exclusion, AmB 5-10uM led to significant cell disruption and lysis. Studies with AmB greater than 5uM were not pursued and were deemed not clinically relevant. No affect on cell viability was observed with lipid formulation concentrations less than10uM.
Immunohistochemistry for Amphotericin B
Tissue sections appeared intact and revealed substantial staining for polyene treated sections compared to controls. In kidney sections, increased staining (increased brown color) was evident from AmB < AmBHP < AmB lipid complex compared to control (Fig. 2) . AmB lipid complex differential staining compared to AmB should be associated with the higher dose of polyene. Similar staining was evident in liver, lung and spleen, however, less dramatic (data not shown). Unique to kidney samples, there appeared to be significantly more uptake in some renal tubular epithelial cells within the same section of tissue. In general, these data support the staining characteristics published previously [10] . Unfortunately, the magnification achievable with light microscopy does not allow discrimination of focal areas of staining.
Transmission Electron Micrograph Study
Even though an occasional damaged cell was evident, hypaq ficol isolation of mononuclear cells appeared robust. Cells were relatively round with some dendritic or areas of spreading (Figs. 3 & 4) . By 120 minutes, AmB stimulated cells appeared activated (fingers, dense granules, irregular borders, fingers or pseudopods, etc.). An occasional platelet was visible at 25,000 to 35,000 times magnification. Platelet contamination of the sample was unavoidable, yet, minimal.
Undamaged cells had significant AmB binding foci compared to control exposed cells at time points greater than 20 minutes. The majority of AmBAg accumulation appeared to be within localized points or vesicles which look similar to lysosomes. We suggest that the vesicles or bodies are digestive vacuoles or dense granules that occur in white blood cells. Accumulation or collection of AmBAg does not appear to be dependent on time. There are not vesicles with large numbers of AmBAg, nor are the large quantities free in the cytoplasm or attached to the cell membrane. However, due to the known rapid cycling of these vesicles, one could hypothesize that our cross sections of time captured did not allow full elucidation of the cycle. Since cholesterol is abundant on mammalian cells, one could expect random binding of AmB to cell surfaces. One can observe that AmB binding does not appear to be random. Intact cell membranes can be observed without any visible AmbAg complexes, yet, one can observe clusters of drug in localized points. Binding characteristics of L-AmB and ABLC exposure lead to identical electronic micrograph observations (data not shown). Based on the biologic assessments that phagocytic cells internalize 100% of their plasma membrane every few hours, one might expect to also find substantial internalized cell membrane or free AmB intracellularly if binding was random to cell wall cholesterol. However, none were visible. Alternatively, at very high LDL Fig. (5) . A hypothesized model of amphotericin b's interaction with a mammalian cell at concentrations routinely found in the serum.
concentrations, LDL binds to specific coated pits (concave clathrin coated areas of cell membrane) and known to be internalized into endosomes after short periods. The biology of hormones support the electron micrograph observations.
DISCUSSION
It is clear that AmB binds to multiple tissues. Autopsy studies evaluating drug penetration suggest that adipose is the only tissue without significant quantities of AmB [11] . Immuno-histochemistry, as a tool for tracking drug movement revealed AmB binding to kidney, liver, lung and spleen (Fig. 2) . Similar studies have been performed demonstrating preferential binding after several days of therapy in spleen, then liver, kidney and lung [10] . Immunopositive staining was evident on the cytoplasm of Kupfer cells. Due to the sensitivity of staining, it was difficult to discern anatomical intracellular binding sites on tissue. One could conclude that binding appeared on and in cells tested.
Transmission micrograph revealed AmB clusters on the cell's surface. These clusters appear to be in "pits" that could lead one to hypothesize that binding is not diffuse. In one image ( Fig. 4; A30-2) , one can visualize the leading edge of a leukocyte with indentations (pits) filled with AmBAg. Based on known AmB binding to lipoproteins, one could also hypothesize these pits are the clarthrin coated or lipid receptors. Generally, the time required to process a ligand can range 5 minutes or longer. Once LDL receptors are internalized, endocytic vesicles contain ~6% clathrin by volume, or ~8% of the wall surface area. Kinetic studies have long shown that these receptors recycle back to the cell surface at a half-life of ~ 5 minutes [12] . Since the process is dyanamic and with excess AmB relative to "receptors", our experiments may have captured mature receptor + ligand (AmB + Lipoprotein) processing in motion (Fig. 5) . Literature to support this hypothesis includes years of lipoprotein research.
Brajtburg and coworkers initially examined the interactions of AmB with human serum lipoproteins in vitro in an attempt to understand these interactions and how they might affect the pharmacological behavior of AmB. Their studies showed AmB to be equally associated with highdensity lipoprotein (HDL) and low-density lipoprotein (LDL) fractions after 1 hour of incubation at 25°C [13] . Furthermore, AmB and LDL mixtures injected into rabbits was toxic: 70% of the rabbits died from a non-toxic dose of AmB (1.0 mg/kg), which implies that LDL association would increase AmB cellular uptake/binding and toxicity [13] .
These same investigators previously demonstrated that HDL-associated AmB 20uM and HDL-associated L-AmB 20uM are less toxic to LLC PK1 renal cells than are AmB or LDL-associated AmB. The reduced toxicity of HDLassociated AmB may be explained by the low level of expression of HDL receptors in LLC PK1 cells. The sustained toxicity observed with AmB alone in trypsinized cells may be related to a direct membrane effect. However, when AmB is associated with LDL, the toxicity is maintained, which suggests that both direct membrane-and non-membrane-related toxicity may occur. Furthermore, a study to determine if a relationship existed between serum lipoprotein cholesterol concentration and the severity of AmB-induced renal toxicity in patients suggested that patients with higher serum LDL-cholesterol concentrations are more susceptible to AmB-induced renal toxicity [13] . Interestingly, AmB complexed with lipid is less toxic than the self associated form of AmB in medium, but the monomeric form of AmB interacts with fungal cells membrane and is non-toxic against mammalian cells membrane [14] .
The results we obtained previously demonstrated that changes in temperature and association with lipid-complexes affect the distribution of AmB in serum lipoproteins [13] . Similar to the results reported by Brajtburg et al., when serum lipoproteins were separated by affinity chromatography, an equal distribution of AmB was found in human serum lipoprotein fractions following one-hour incubation at 25°C [15] . In contrast, at 37°C, over 90% of the concentration of AmB was found in the HDL fraction following 1 hour incubation. However, recent studies in our lab using density gradient ultracentrifugation to separate plasma lipoproteins suggest this is an overestimation of the percentage of AmB recovered in the HDL fraction. Between 66-80% of the original concentration incubated in plasma was recovered in the lipoprotein-deficient plasma fraction, which contains mainly albumin and B-1-glycoprotein. This inconsistency in results is due to the limitation of the affinity chromatography technique in determining the lipoprotein distribution of drugs. This technique can only separate LDL and VLDL away from the other plasma proteins and lipoproteins. It cannot separate HDL from the plasma proteins (albumin and B-1-glycoprotein). Using densitygradient ultracentrifugation, the different lipoproteins can be separated away from plasma proteins. The core of HDL becomes more ordered at the higher temperature, thus making it easier for the AmB molecule to associate with it. This hypothesis is based on the assumption that AmB is incorporated into the lipophilic core of these lipoproteins. A final argument for the proposed hypothesis has been the affects of LDL. Studies that have blocked the LDL receptor by pre-incubating CHO cells with trioleoyl glycerol triolein bound LDL demonstrated AmB associated cellular toxicity is abolished [16] .
Transmission electron micrograph studies in lipid research reveal support for our proposed hypothesis. When human umbilical artery endothelial cells were cultured for 18 hours in LDL depleted serum, to increase LDL receptor density, LDL bound to gold beads could be found in large vesicles with an electron-lucent matrix and smooth membranes (endosomes) [17] . In these studies, gold labeled LDL (30-50 ug/protein/mL) was incubated for 5, 15, and 30 minutes at 37 o C with cells and then washed. By 30 minutes, endosomes could be found that contained electron-dense particles close to endosome membranes. After short periods, internalization of LDL into endosomes had already started. These authors suggest that the LDL plus gold is too large to undergo pinocytosis (low-affinity pathway). They hypothesized that, since LDL delivery and degradation of LDL had been established in the literature, it may be reasonable to assume the dense bodies are lysosomes containing degraded LDL and the gold-antibody.
Kinsky et al., was one of the first to describe transmission electron micrograph changes associated with a polyene [18] . These researchers were using a polyene to track cholesterol. They described pits (200-250 A o ) in rat erythrocytes formed by filipin. Pit formation appeared to be dependent on cholesterol content. They hypothesized the formed pits were a sign of membrane destabilization. However, another interpretation of these observations could lead one to conclude that cholesterol (LDL) bound polyene attach in those clathrin coated pits. Filipin, a polyene, binds specifically to cholesterol and has also had widespread use as a histiochemical fluorescent stain. Yet, filipin is a pentaene antibiotic which does not contain a carboxyl group or mycosamine sugar moiety and the affinity of filipin to cholesterol is stronger than to ergosterol [6, 19] .
Experiments evaluating cellular quantities of AmB have lead to varying estimates, yet are insightful. Subtractive absorption spectrophotometry using a fluorescence probe ( 7 M AmB per cell using the above estimates. More plausible estimates are obtained by other methodologies. Determination of monocyte associated drug by scanning spectrophotometry (350 to 450nm) was performed using overnight co-incubation, lysing and assay of intracellular fluid assayed. The absorbance difference between the trough at 398 nm and the peak at 408 nm was determined. Incubation with AmB 1.0uM resulted in intracellular concentrations, as early as 30 minutes that progressively increased over 20 hours to a maximum of ~50fg/cell or an estimated intracellular concentration of ~100pM (assuming a cell volume of 500 fL per cell) [21] . Phagocytic cells have been shown to accumulate AmB 0.8 & 3.5 ng/10 6 peritoneal exudative cell and L-AmB 4.4 & 7.9ng/10 6 cells in vivo at 6 and 24 hours after AmB administration [22] . Performing a similar calculation, they are estimating 160pM to 7000pM and 8800pM to 15,800pM for AmB and a liposomal formulation. Combined, these studies support that therapeutic concentrations of AmB do not bind to all cellular associated cholesterol.
Recent studies on cholesterol regulation suggests ABCA1 localizes to the plasma membrane and is functional in the efflux of excess cellular cholesterol into high-density lipoprotein particles. The sub-cellular localization of the ABCA2 transporter in lysosomes suggested a possible role for ABCA2 in regulating the movement or efflux of LDL from the lysosme to the plasma membrane and endoplasmic reticulum [23] . Our pharmacogenomic data support upregulation of transcripts (ABCA 2, LDLR, HMGCoA S AND SREBP2) associated with the lipid export machinery during AmB exposure. These suggest that lipid bound AmB may activate a signal transduction pathway in mononuclear cells [24, 25] .
CONCLUSION
Significant binding of AmB to low density lipoproteins, accumulation of AmB within white blood cell vesicles, digestive vacuoles or dense granules supports a new hypothesis for polyene interaction with human cells. We propose an alternate hypothesis of polyene binding. AmB, at pharmacotherapeutically achievable serum concentrations, binds preferentially to soluble serum lipoproteins. We suggest that this AmB -cholesterol ligand is collected into clathrin coated pits and enters into intercellular trafficking and signaling. Previous literature supports signaling activation and secondary cellular protein expression (i.e. inflammatory cytokines, apoptosis) [26] . What is unclear are the events transpiring in the digestive vacuoles leading to protein expression. It is known that primary lysosomes (25-50nm) empty their contents into vacuoles to digest their contents. These secondary lysosome(<400nm) or endosomes dump their digested contents back into the extracellular space [12] . Continued exploration of this hypothesis will be required to elucidate the fate of endocytosed AmB.
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